Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

U.S. Market for Neurostimulation Devices Will Reach Almost $4 Billion by 2022

April 9, 2014 By PR Newswire

Decision Resources Group finds that the approval of new indications—particularly chronic heart failure, obesity and epilepsy—will expand the patient pool and market potential for neurostimulation devices in the United States considerably, allowing the market to reach a value approaching $4 billion by 2022. Most notably, because neurostimulation is already well accepted as a treatment for epilepsy, the Food and Drug Administration’s (FDA) approval in 2013 of NeuroPace’s deep brain stimulation (DBS) device for this indication will lead to rapid adoption of this product.

Other key findings from the Medtech 360 report entitled US Markets for Neurostimulation Devices 2014:

  • Replacement devices: Demand for replacement of implantable pulse generators will drive market expansion. Through 2022, many devices that were implanted in first-time patients will reach the end of their life spans, and replacement devices will be required.
  • Complex reimbursement process: Although reimbursement is available for most indications, the approval process for eligible patients is extensive and complex; the process carries high up-front costs in some cases and can be so lengthy that some patients decide to forgo this treatment altogether.
  • Alternative treatments: Due to the invasive nature of neurostimulation therapy, some patients will also prefer alternative treatments such as lifestyle and medical management for most indications where feasible.
  • Market leader Medtronic: Medtronic holds more than half of the overall revenues in this market. The company has a first-mover advantage and has thus far maintained its monopoly in the DBS, sacral nerve stimulation and gastric electric stimulation device segments.

Comments from Decision Resources Group Analyst Roald Dhoska:

  • “Many companies are attempting to enter the U.S. neurostimulation device market to capitalize on strong revenue growth. Boston Scientific is seeking FDA approval of its DBS system, Nevro Corp and Spinal Modulation are both running clinical trials for spinal cord stimulation products and numerous competitors are racing to capitalize on the market potential by expanding indications in the vagus nerve stimulation segment.”
  • “Penetration into the eligible patient populations for most devices is low because many referring physicians are not exposed to neurostimulation in medical school. New manufacturers looking to enter the market will be well positioned for success if they can implement educational campaigns that target these physicians.”

Related Articles Read More >

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders
Withings Body Scan
Withings plans launch for Body Scan smart scale platform
BinaxNow COVID-19 Ag Card
Time recognizes Abbott offerings among this year’s 100 best inventions
Koya Medical’s Dayspring device
Koya Medical reports positive early results in Dayspring lymphedema trial

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech